Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations

Name: Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
SKU: 3279
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 4 Articles Tags: antipsychotic, deanna-l-kelly, medworks-media, pharmacodynamic, pharmacokinetic, psychopharmacology-bulletin, qtc-interval, raymond-c-love, torsades-de-pointes, ziprasidone

Description

Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations

Description

Deanna L. Kelly, PharmD, BCPP

DRUG INTERACTIONS

Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations

Deanna L. Kelly, PharmD, BCPP, and Raymond C. Love, PharmD, BCPP, FASHP

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations

Description

Deanna L. Kelly, PharmD, BCPP

DRUG INTERACTIONS

Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations

Deanna L. Kelly, PharmD, BCPP, and Raymond C. Love, PharmD, BCPP, FASHP

Related products

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa